The proton-pump inhibitors: Similarities and differences
- 1 March 2000
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (3), 266-280
- https://doi.org/10.1016/s0149-2918(00)80032-6
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Regression of columnar‐lined (Barrett’s) oesophagus with omeprazole 40 mg daily: results of 5 years of continuous therapyAlimentary Pharmacology & Therapeutics, 1999
- Review article: the pharmacology of rabeprazoleAlimentary Pharmacology & Therapeutics, 1999
- Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer—a European multicentre studyAlimentary Pharmacology & Therapeutics, 1998
- Short‐term low‐dose pantoprazole‐based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patientsAlimentary Pharmacology & Therapeutics, 1998
- LansoprazoleDrugs, 1997
- Long‐term treatment with lansoprazole for patients with Zollinger–Ellison syndromeAlimentary Pharmacology & Therapeutics, 1996
- Zollinger-Ellison SyndromeDrugs, 1996
- PantoprazoleDrugs, 1996
- The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanismGastroenterology, 1994
- Use of omeprazole in patients with Zollinger-Ellison syndromeDigestive Diseases and Sciences, 1991